GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Cavitation Technologies Inc (OTCPK:CVAT) » Definitions » Change In Receivables

CVAT (Cavitation Technologies) Change In Receivables : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Cavitation Technologies Change In Receivables?

Cavitation Technologies's change in receivables for the quarter that ended in Dec. 2024 was $0.00 Mil. It means Cavitation Technologies's Accounts Receivable stayed the same from Sep. 2024 to Dec. 2024 .

Cavitation Technologies's change in receivables for the fiscal year that ended in Jun. 2024 was $0.00 Mil. It means Cavitation Technologies's Accounts Receivable stayed the same from Jun. 2023 to Jun. 2024 .

Cavitation Technologies's Accounts Receivable for the quarter that ended in Dec. 2024 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Cavitation Technologies's Days Sales Outstanding for the three months ended in Dec. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Cavitation Technologies's liquidation value for the three months ended in Dec. 2024 was $-0.05 Mil.


Cavitation Technologies Change In Receivables Historical Data

The historical data trend for Cavitation Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cavitation Technologies Change In Receivables Chart

Cavitation Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.10 0.01 - -

Cavitation Technologies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cavitation Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cavitation Technologies  (OTCPK:CVAT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Cavitation Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0.076*91
=0.00

2. In Ben Graham's calculation of liquidation value, Cavitation Technologies's accounts receivable are only considered to be worth 75% of book value:

Cavitation Technologies's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.681-0.741+0.75 * 0+0.5 * 0.011
=-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cavitation Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Cavitation Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Cavitation Technologies Business Description

Traded in Other Exchanges
N/A
Address
10019 Canoga Avenue, Chatsworth, CA, USA, 91311
Cavitation Technologies Inc is a ESG company, that designs and manufactures flow-through nano-technology systems for fluid processing applications. The technology is implemented in multiple applications, such as water treatment and remediation, agriculture, pharmaceuticals, edible oil refining, renewable fuels, and beverages. Its core products are Nano Reactor systems, with scalable capacities ranging from nearly10 to 500 gallons per minute (GPM), and Cavitation Non-Thermal Plasma technology, which currently operates at nearly 14 GPM and has a scalability of up to nearly 100 GPM. These systems effectively eliminate bacteria and viruses, reduce TDS levels, lower turbidity, and offer the potential removal of PFAS in multiple water remediation applications.
Executives
Naum Voloshin officer: Chief Financial Officer 10019 CANOGA AVENUE, CHATSWORTH CA 91311
Roman Gordon director, 10 percent owner, officer: CEO, Secretary 10019 CANOGA AVENUE, CHATSWORTH CA 91311
Todd Zelek director, officer: CEO 730 SOUTH SAN RAFAEL AVENUE, PASADENA CA 91105
James W Fuller director C/O BAYTREE CAPITAL ASSOCIATES LLC, 40 WALL STREET, 58TH FLOOR, NEW YORK NY 10005
Igor Gorodnitsky director, 10 percent owner, officer: President 10019 CANOGA AVENUE, CHATSWORTH CA 91311
R L Hartshorn director, 10 percent owner, officer: CFO 10019 CANOGA AVENUE, CHATSWORTH CA 91311
Jose Antonio Castro director, 10 percent owner, officer: CEO & CFO 3702 SOUTH VIRGINIA STREET, #G12-401, RENO NV 89502
Zhang Haiming director, 10 percent owner, officer: Chief Technology Officer 3702 SOUTH VIRGINIA STREET, #G12-401, RENO NV 89502

Cavitation Technologies Headlines

From GuruFocus